Viridian Therapeutics Inc. (VRDN)
NASDAQ · Healthcare
Viridian Therapeutics Inc. Operating Income 2013–2025
Viridian Therapeutics Inc. annual/quarterly operating income history and growth rate from 2013 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Viridian Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -116.2 M, a 23.76% increase year-over-year.
- Viridian Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -356.8 M, a 35.78% increase year-over-year.
- Viridian Therapeutics Inc. annual operating income for 2025 was -363.4 M, a 21.52% increase from 2024.
- Viridian Therapeutics Inc. annual operating income for 2024 was -299.0 M, a 17.52% increase from 2023.
- Viridian Therapeutics Inc. annual operating income for 2023 was -254.4 M, a 89.46% increase from 2022.
- Viridian Therapeutics Inc. annual operating income for 2022 was -134.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Viridian Therapeutics Inc. Operating Income — FAQ
Viridian Therapeutics Inc. (VRDN) operating income over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is Viridian Therapeutics Inc.'s operating income?
Viridian Therapeutics Inc. (VRDN) reported operating income of -$363M for fiscal 2025.
Where can I see VRDN's operating income history?
The chart and table above show Viridian Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.